Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpretation of Change in Novel Digital Measures: A Statistical Review and Tutorial.

Digital biomarkers·2025
Same author

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data.

Statistics in medicine·2024
Same author

Correction to "Using principal stratification in analysis of clinical trials".

Statistics in medicine·2024
Same author

Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation.

Digital biomarkers·2023
Same author

Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder.

Therapeutic innovation & regulatory science·2023
Same author

Overview of modern approaches for identifying and evaluating heterogeneous treatment effects from clinical data.

Clinical trials (London, England)·2023

Related Experiment Video

Updated: May 15, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models.

Bohdana Ratitch1, Michael O'Kelly, Robert Tosiello

  • 1Quintiles, Montreal, Quebec, Canada.

Pharmaceutical Statistics
|January 8, 2013
PubMed
Summary

This study introduces pattern mixture models to address missing data in clinical trials. These models offer a transparent framework for implementing robust statistical analyses based on realistic clinical assumptions, enhancing data integrity.

Keywords:
clinical assumptionsmissing datamultiple imputationpattern mixture modelssensitivity analysis

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Experiment Videos

Last Updated: May 15, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Data Management

Background:

  • Increasing regulatory and academic focus on rigorous methods for handling missing data in clinical trials.
  • Current guidelines emphasize minimizing missing data and selecting primary analysis methods based on missingness mechanism assumptions.
  • Need for sensitivity analyses to stress-test primary findings under various assumptions.

Purpose of the Study:

  • To explore strategies for managing missing data in clinical trials using pattern mixture models.
  • To provide a transparent framework for translating clinical assumptions into statistical analyses.
  • To facilitate the implementation of complex missing data methods.

Main Methods:

  • Utilized pattern mixture models to develop strategies for dealing with missing data.
  • Focused on approaches that embody clear and realistic clinical assumptions.
  • Provided implementation details for specific strategies in an appendix.

Main Results:

  • Pattern mixture models offer a statistically sound and transparent framework for missing data analysis.
  • The proposed strategies allow for the translation of clinical assumptions into statistical analyses.
  • General principles enable implementation of various analyses with different missing data assumptions.

Conclusions:

  • Pattern mixture models represent a valuable tool for addressing missing data in clinical trials.
  • These models enhance the interpretability and scientific justification of analyses involving missing data.
  • The approach supports robust and transparent handling of missingness, aligning with regulatory expectations.